20th Anniversary of the Abortion Pill Mifepristone’s Approval By Randall K. O’Bannon, Ph.D., NRL Director of Education & Research The first principle of medical ethics is “primum non nocere” – “first, do no harm.” It is a reminder that at a patient’s most physically vulnerable moment, a doctor must take care with all his sharp tools …
Continue reading "The Day the FDA Abandoned the First Principle of Medical Ethics"
By Dave Andrusko SB 24, a bill that would force student health centers at all University of California and California State University campuses to offer abortifacient drugs beginning in January 1, 2023 passed the Senate Health Committee Wednesday on a vote of 7-3. According to Jenni Fink, “There are 10 campuses within the University of …
Continue reading "Ca. Senate committee approves bill to provide abortifacient drugs on all public colleges and universities"
By Dave Andrusko On Monday, the FDA sent warning letters to two online entities for introducing “Misbranded and Unapproved New Drugs into Interstate Commerce,” specifically mifepristone and misoprostol, the two drugs that make up the “RU-486”abortion technique. AidAccess.org and Rablon were told to immediately stop selling unapproved versions of the drugs and to “respond to …
Continue reading "FDA sends warning letters to two entities selling mislabeled and unapproved abortion drugs over the Internet"
By Dave Andrusko Back in late April, Kansans for Life stood tall in a battle over a bill to expand “telemedicine” so as to reinforce the state law that requires that a doctor be physically present when a woman takes the first of two drugs that make up a chemical abortion, aka RU-486, and to …
Continue reading "Wichita abortion clinic challenges Kansas “medical abortion” law"
By Dave Andrusko Editor’s note. My family and I will be on our vacation through September 7. I will occasionally add new items but for the most part we will repost “the best of the best” — the stories our readers have told us they especially liked. For many years the only data from the FDA …
Continue reading "Updated FDA reports at least 22 deaths associated with chemical abortions (RU-486 abortions)"
By Dave Andrusko Less than a month after a judge upheld the Scottish government’s decision to allow women to take the abortifacient drug misoprostol at home, the British government announced over the weekend that by the end of the year home use of misoprostol will be legalized. Misoprostol is the second drug of the two-drug …
Continue reading "British government authorizes home use of second abortifacent pill, SPUC vows legal action"
SPUC “extremely disappointed that our concerns have not been upheld” By Dave Andrusko Following a two day hearing in May that took place at Edinburgh’s Court of Sessions, Judge Lady Wise has ruled that the Scottish Government’s decision to allow women to take the abortifacient drug misoprostol at home is “not unlawful.” Misoprostol is the …
Continue reading "Court upholds Scottish Govt’s decision to allow women to take abortifacient at home"
Academic journal publishes flawed article promoting home abortions and ignores criticism. By SPUC—the Society for the Protection of Unborn Children Editor’s note. Misoprostol is one of the drugs that make of the two-drug RU-486 abortion technique. The British Medical Journal’s journal BMJ Sexual & Reproductive Health journal has refused to publish any criticism of a …
Continue reading "BMJ Sexual & Reproductive Health refuses to publish criticism of article promoting DIY home abortions"
By Dave Andrusko Periodically a story will update the proposal that would require the on-campus health centers of public universities in California to offer abortion-inducing drugs such as RU-486. If enacted into law, California would have the dubious distinction of being the first state to create such a mandate. A story that appeared this week, …
Continue reading "College co-ed complains she had to go six miles to abort, insists college health centers should provide chemical abortifacients"
By Randall K. O’Bannon, Ph.D. NRL Director of Education & Research Editor’s note. Part One of Dr. O’Bannon story ran on Tuesday. He provided an extensive background to the history of chemical abortions and how abortionists have ignored protocols in a ceaseless effort to make more money off of chemical abortions (“RU-486”) and pave the …
Continue reading "Chemical Abortions: The pro-abortion plan if abortions become substantially harder to obtain — Part Two"
By Randall K. O’Bannon, Ph.D. NRL Director of Education & Research Editor’s note. This appeared in the latest issue of National Right to Life News. Part Two will run on Wednesday. I trust you are enjoying this 41-page edition and are sharing its contents with family and friends. Ever wonder why the industry developed the …
Continue reading "Chemical Abortions: The pro-abortion plan if abortions become substantially harder to obtain — Part One"
By Dave Andrusko A highly interesting story ran today in Inside Philanthropy (“Who’s funding what, and why?”) headlined, “The Nonprofit Funding Research to Change the Conversation Around Abortion Access” and written by Caitlin Reilly. Spoiler alert. We’ll develop this over the next 300 words or so, but here is her conclusion: These are challenging times …
Continue reading "Having underwritten development of RU486, Susan Thompson Buffett Foundation now trying to make chemical abortions “more accessible”"